BRAINSTORM CELL THERAPEUTICS (BCLI)

US10501E2019 - Common Stock

2.28  +0.2 (+9.62%)

After market: 2.29 +0.01 (+0.44%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/AN/A
170.09%		N/A
72.02%		N/A
-25.60%
EBITDA
YoY % growth
-4.94M-7.31M
-47.98%		-8.45M
-15.60%		-5M
40.83%		-4.91M
1.80%		-13.95M
-184.11%		-22.84M
-63.73%		-31.46M
-37.74%		-24.28M
22.82%		-24.53M
-1.03%		-21.174M
13.68%		N/A
32.56%		N/A
-7.14%		N/A
-53.33%		N/A
26.09%		N/A
494.12%		N/A
174.63%		N/A
66.85%		N/A
EBIT
YoY % growth
-5.04M-7.42M
-47.22%		-8.54M
-15.09%		-5.08M
40.52%		-5M
1.57%		-14.06M
-181.20%		-23M
-63.58%		-31.68M
-37.74%		-24.54M
22.54%		-24.82M
-1.14%		-21.439M
13.62%		N/A
39.01%		N/A
-91.44%		N/A
-11.87%		N/A
3.17%		N/A
184.56%		N/A
-49.68%		N/A
471.19%		N/A
153.19%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/A-6.75
-26.05%		-4.20
37.78%		-4.05
3.57%		N/A
-115.33%		-15.90
-82.32%		-16.20
-1.89%		-10.20
37.04%		-9.90
2.94%		N/A
-8.18%		N/A
75.43%		N/A
4.46%		N/A
8.72%		N/A
49.33%		N/A
225.88%		N/A
55.05%		N/A
95.06%		N/A
1.61%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.37
-143.33%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-3.397M
29.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.51
-264.29%		-0.590.0813.04%
Q2 2024
Q2Q % growth		 -0.60
85.19%		-0.54-0.06-12.04%
Q1 2024
Q2Q % growth		 -0.75
64.29%		-1.070.3229.97%
Q4 2023
Q2Q % growth
92.15%		-0.15%
Q3 2023
Q2Q % growth		 -0.14
95.09%		-0.140.001.96%
Q2 2023
Q2Q % growth		 -4.05
-42.11%		-2.30-1.76-76.47%
Q1 2023
Q2Q % growth		 -2.10
6.67%		-2.520.4216.82%
Q4 2022
Q2Q % growth		 -1.95
23.53%		-2.220.2712.10%
Q3 2022
Q2Q % growth		 -2.85
-26.67%		-2.75-0.10-3.49%
Q2 2022
Q2Q % growth		 -2.85
-11.76%		-2.24-0.61-27.00%
Q1 2022
Q2Q % growth		 -2.25
21.05%		-1.99-0.26-13.12%
Q4 2021
Q2Q % growth		 -2.55
54.05%		-3.010.4615.26%
Q3 2021
Q2Q % growth		 -2.25
-7.14%		-3.140.8928.26%
Q2 2021
Q2Q % growth		 -2.55
32.00%		-3.010.4615.26%
Q1 2021
Q2Q % growth		 -2.85
40.62%		-3.981.1328.36%
Q4 2020
Q2Q % growth		 -5.55
-8.82%		-6.661.1116.61%
Q3 2020
Q2Q % growth		 -2.10
44.00%		-3.981.8847.21%
Q2 2020
Q2Q % growth		 -3.75
-8.70%		-3.980.235.73%
Q1 2020
Q2Q % growth		 -4.80
-33.33%		-3.44-1.36-39.43%
Q4 2019
Q2Q % growth		 -5.10
-25.93%		-2.70-2.40-88.68%
Q3 2019
Q2Q % growth		 -3.75
-66.67%		-3.37-0.38-11.41%
Q2 2019
Q2Q % growth		 -3.45
-43.75%		-3.670.226.05%
Q1 2019
Q2Q % growth		 -3.60 -1.15-2.45-213.73%
Q4 2018
Q2Q % growth		 -4.05 -2.14-1.91-89.08%
Q3 2018
Q2Q % growth		 -2.25 -1.45-0.80-54.80%
Q2 2018
Q2Q % growth		 -2.40 -1.76-0.64-36.40%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2019
Q2Q % growth		 765K-765K-100.00%
Q1 2019
Q2Q % growth		 765K-765K-100.00%
Q4 2018
Q2Q % growth		 765K-765K-100.00%
Q3 2018
Q2Q % growth		 765K-765K-100.00%
Q2 2018
Q2Q % growth		 1.53M-1.53M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-421.43% -421.43% 0% -1333.33%
RevenueN/A N/A N/A N/A